Naga P. Chalasani, MD | IU Health

Dr. Naga Chalasani, MD

Claim this profile

Indiana University

Studies Fatty Liver
Studies Non-alcoholic Fatty Liver Disease
7 reported clinical trials
12 drugs studied

Affiliated Hospitals

Image of trial facility.
Indiana University
Image of trial facility.
Indiana University School Of Medicine

Clinical Trials Naga Chalasani, MD is currently running

Image of trial facility.

Biomarker Screening

for Liver Cancer

The National Liver Cancer Screening Trial is an adaptive randomized phase IV Trial comparing ultrasound-based versus biomarker-based screening in 5500 patients with cirrhosis from any etiology or patients with chronic hepatitis B infection. Eligible patients will be randomized in a 1:1 fashion to Arm A using semi-annual ultrasound and AFP-based screening or Arm B using semi-annual screening using GALAD alone. Randomization will be stratified by sex, enrolling site, Child Pugh class (A vs. B), and HCC etiology (viral vs. non-viral). Patients will be recruited from 15 sites (mix of tertiary care and large community health systems) over a 3-year period, and the primary endpoint of the phase IV trial, reduction in late-stage HCC, will be assessed after 5.5 years.
Recruiting3 awards Phase 44 criteria

More about Naga Chalasani, MD

Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Naga Chalasani, MD has experience with
  • AFP
  • GALAD
  • Liver Ultrasound
  • Omega-3 Fatty Acid (DHA EE)
  • Vitamin E [(all-rac)-α-tocopheryl Acetate]
  • No Investigational New Treatment
Breakdown of trials Naga Chalasani, MD has run
Fatty Liver
Non-alcoholic Fatty Liver Disease
Diabetic Liver Disease
Hepatitis B
Hepatocellular Carcinoma

Other Doctors you might be interested in

Lisa LandrumIndiana University Simon Cancer Center
Rafat Abonour, MDIndiana University/Melvin and Bren Simon Cancer Center
Craig Lammert, MDIndiana University

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Naga Chalasani, MD specialize in?
Naga Chalasani, MD focuses on Fatty Liver and Non-alcoholic Fatty Liver Disease. In particular, much of their work with Fatty Liver has involved treating patients, or patients who are undergoing treatment.
Is Naga Chalasani, MD currently recruiting for clinical trials?
Yes, Naga Chalasani, MD is currently recruiting for 1 clinical trial in Indianapolis Indiana. If you're interested in participating, you should apply.
Are there any treatments that Naga Chalasani, MD has studied deeply?
Yes, Naga Chalasani, MD has studied treatments such as AFP, GALAD, Liver Ultrasound.
What is the best way to schedule an appointment with Naga Chalasani, MD?
Apply for one of the trials that Naga Chalasani, MD is conducting.
What is the office address of Naga Chalasani, MD?
The office of Naga Chalasani, MD is located at: Indiana University, Indianapolis, Indiana 46202 United States. This is the address for their practice at the Indiana University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top